FDAnews Drug Daily Bulletin

BIOCRYST ANNOUNCES $30.0 MILLION COMMON STOCK OFFERING TO INSTITUTIONAL INVESTORS

Dec. 16, 2005
A A

BioCryst Pharmaceuticals, Inc. today announced that it has signed a definitive agreement for a $30.0 million registered direct offering of 2,228,829 shares of its common stock to a group of institutional investors including Kleiner Perkins Caufield & Byers and Texas Pacific Group Ventures. The shares of common stock, priced at $13.46 per share, were registered pursuant to BioCryst's shelf registration statements that were declared effective by the Securities and Exchange Commission on January 5, 2004 and September 20, 2005.

Yahoo News (http://biz.yahoo.com/prnews/051215/nyth055.html?.v=31)